Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis

Yu-Chen Wang, Noruel Gerard Salvador, Chih‐Che Lin, Chao-Chien Wu, Ting‐Lung Lin, Wei-Feng Lee, Yi‐Chia Chan, Chao‐Long Chen, Jeffrey Samuel Co, Domelle Dave Encarnacion

Biomedical Journal · 2020 · 12 citations · 26 references

DOIFull text

Open access

Abstract

The use of RFB in LDLT recipients with active TB, had a lesser drug interaction than when RFM was used. However, RFB did not significantly reduced the rate of ACR. RFB and RFM are both effective and safe to use in LDLT recipients with active TB.

References

26